Indication
Typhoid Fever
8 clinical trials
14 products
1 drug
Clinical trial
Phase 4 Observational Prospective Cohort Study to Assess the Safety of Vivotif at Different Release Titers Among TravelersStatus: Completed, Estimated PCD: 2016-10-06
Product
VivotifClinical trial
A Cluster-randomised Controlled Phase IV Trial Assessing the Impact of a Vi-Polysaccharide Conjugate Vaccine in Preventing Typhoid Infection in Asante Akim, Ghana (TyVEGHA)Status: Recruiting, Estimated PCD: 2024-12-31
Product
Vi-TTClinical trial
WHNRC (Western Human Nutrition Research Center) Fiber Intervention StudyStatus: Recruiting, Estimated PCD: 2025-09-30
Product
Ty21a Typhoid Fever VaccineProduct
Typhoid Conjugate VaccineProduct
MCV-AClinical trial
Azithromycin and Cefixime Combination Versus Azithromycin Alone for the Out-patient Treatment of Clinically Suspected or Confirmed Uncomplicated Typhoid Fever in South Asia; a Randomised Controlled TrialStatus: Recruiting, Estimated PCD: 2024-07-30
Product
AzithromycinProduct
CefiximeDrug
VarlilumabClinical trial
Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) VaccinesStatus: Recruiting, Estimated PCD: 2025-12-01
Product
Oral typhoid fever vaccineProduct
Oral cholera vaccineClinical trial
Induction of Gut Permeability by an Oral VaccineStatus: Active (not recruiting), Estimated PCD: 2022-01-31
Product
Vivotif Typhoid Oral VaccineProduct
AspirinClinical trial
Understanding Typhoid Disease After Vaccination: a Single Centre, Randomised, Doubleblind, Placebo Controlled Study to Evaluate M01ZH09 in a Healthy Adult Challenge Model, Using Ty21a Vaccine as a Positive Control.Status: Completed, Estimated PCD: 2015-12-01
Product
Vaccine placeboProduct
Ty21aProduct
M10ZH09 vaccine